These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8061424)

  • 1. Intraluminal contrast agents for MR imaging of the abdomen and pelvis.
    Pels Rijcken TH; Davis MA; Ros PR
    J Magn Reson Imaging; 1994; 4(3):291-300. PubMed ID: 8061424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL; Muller HH; Young SW
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoluminal contrast for abdomen and pelvis magnetic resonance imaging.
    Gupta MK; Khatri G; Bailey A; Pinho DF; Costa D; Pedrosa I
    Abdom Radiol (NY); 2016 Jul; 41(7):1378-98. PubMed ID: 26907710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal contrast agents for MR imaging.
    Brown JJ
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging: safety and imaging characteristics.
    Patten RM; Moss AA; Fenton TA; Elliott S
    J Magn Reson Imaging; 1992; 2(1):25-34. PubMed ID: 1623278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density barium and bentonite mixture versus high density barium: a comparative study to optimize negative gastrointestinal contrast agents for MRI.
    Paley MR; Nicolas AI; Mergo PJ; Torres GM; Burton SS; Ros PR
    Magn Reson Imaging; 1997; 15(9):1033-6. PubMed ID: 9364949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents in abdominal imaging: current and future directions.
    Schneider G; Reimer P; Mamann A; Kirchin MA; Morana G; Grazioli L
    Top Magn Reson Imaging; 2005 Feb; 16(1):107-24. PubMed ID: 16314700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile-tagged 3d magnetic resonance colonography after exclusive intravenous administration of gadobenate dimeglumine, a contrast agent with partial hepatobiliary excretion.
    Knopp MV; Giesel FL; Radeleff J; Von Tengg-Kobligk H
    Invest Radiol; 2001 Oct; 36(10):619-23. PubMed ID: 11577273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal imaging.
    Stark DD; Fahlvik AK; Klaveness J
    J Magn Reson Imaging; 1993; 3(1):285-95. PubMed ID: 8428096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gadolinium-DTPA as an oral contrast medium for MR tomography of the abdomen].
    Krahe T; Dölken W; Lackner K; Houselog M; Habscheid W; Clauss W
    Rofo; 1990 Aug; 153(2):167-73. PubMed ID: 2168072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparison of positive and negative enteral contrast media for the magnetic resonance tomography of the abdomen].
    Kaminsky S; Laniado M; Gogoll M; Clauss W; Langer M
    Rofo; 1994 Sep; 161(3):220-5. PubMed ID: 7919247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers.
    Ros PR; Steinman RM; Torres GM; Burton SS; Panaccione JL; Rappaport DC; McGorray SP
    AJR Am J Roentgenol; 1991 Oct; 157(4):761-7. PubMed ID: 1892032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced MR imaging of the pancreas.
    Kettritz U; Semelka RC
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced magnetic resonance imaging of the abdomen.
    Brown ED; Semelka RC
    Magn Reson Q; 1994 Jun; 10(2):97-124. PubMed ID: 7986704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB; Rappaport DC; Ros PR; Torres GM
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral contrast media for magnetic resonance tomography of the abdomen. 1. Comparative animal studies of positive and negative contrast media].
    Laniado M; Kaminsky S; Semmler W; Weinmann HJ; Zurth C; Claussen C
    Rofo; 1987 Sep; 147(3):325-32. PubMed ID: 2445010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density oral barium sulfate in abdominal MRI: efficacy and tolerance in a clinical setting.
    Burton SS; Liebig T; Frazier SD; Ros PR
    Magn Reson Imaging; 1997; 15(2):147-53. PubMed ID: 9106142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.